BioLine HCV Rapid Test

Description

The BioLine HCV Rapid Test is a rapid diagnostic test designed to detect antibodies to the Hepatitis C Virus (HCV) in blood, plasma, or serum samples. Developed by Abbott , a global leader in healthcare and diagnostics, this test provides a fast and reliable solution for identifying HCV infections in various healthcare settings

The BioLine HCV Rapid Test utilizes advanced immunochromatographic technology, employing specific antigens to detect the presence of HCV antibodies in the sample. Known for its ease of use, this test delivers results within 15-20 minutes, making it an invaluable tool for immediate diagnosis in outpatient clinics, hospitals, or even resource-limited areas. With high accuracy and sensitivity, the test minimizes the risk of false-positive or false-negative results. Additionally, it does not require complex equipment or extensive training, making it suitable for use in primary care settings and community-based initiatives aimed at combating Hepatitis C.